
Ascendis Pharma AS Earnings, Revenue beat In Q2
Investing.com - Ascendis (JO:ASCJ) Pharma AS reported second quarter {{erl-945085||earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts. The firm...
Investing.com - Ascendis (JO:ASCJ) Pharma AS reported second quarter {{erl-945085||earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts. The firm...
Ascendis Pharma (NASDAQ:ASND) reported Q2 EPS of EUR(1.46).
Investing.com - Ascendis (JO:ASCJ) Pharma AS reported first quarter {{erl-945085||earnings that missed analysts' expectations on Wednesday and revenue that topped forecasts. The firm...
Investing.com - Ascendis Pharma AS reported first quarter {{erl-945085||earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts. The firm reported earnings...
Investing.com - Ascendis Pharma AS reported third quarter {{erl-945085||earnings that beat analysts' expectations on Wednesday and revenue that fell short of forecasts. The firm reported...
Investing.com - Ascendis Pharma AS reported second quarter {{erl-945085||earnings that missed analysts' expectations on Wednesday and revenue that topped forecasts. The firm reported...
Investing.com - Ascendis Pharma AS reported first quarter {{erl-945085||earnings that beat analysts' expectations on Thursday and revenue that fell short of forecasts. The firm reported...
Investing.com - Ascendis Pharma AS reported first quarter {{erl-945085||earnings that missed analysts' expectations on Wednesday and revenue that fell short of forecasts. The firm reported...
Investing.com - Ascendis Pharma AS reported third quarter {{erl-945085||earnings that missed analysts' expectations on Wednesday and revenue that topped forecasts. The firm reported...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Telecoms, Healthcare and Industrials sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.